Gene fusion involving the insulin‐like growth factor 1 receptor in an ALK ‐negative inflammatory myofibroblastic tumour

Abstract excerpt

AIMS: Inflammatory myofibroblastic tumour (IMT) is a soft tissue tumour primarily affecting children and young adults. Approximately 50% of IMTs have gene fusions involving the receptor tyrosine kinase (RTK)-encoding ALK gene, providing a molecular rationale for treating IMT patients with unresectable tumours with tyrosine kinase inhibitors (TKI). However, a subset of IMT instead displays fusions affecting other...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to IgG4-Related and Inflammatory Diseases
• Share to Neuroendocrine Tumor Research Advances
• Share to Soft tissue tumor case studies